Lord, Abbett & Co’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-102,289
| Closed | -$4.19M | – | 933 |
|
|
2017
Q3 | $4.19M | Buy |
102,289
+44,260
| +76% | +$1.81M | 0.01% | 790 |
|
|
2017
Q2 | $1.75M | Sell |
58,029
-979
| -2% | -$29.5K | 0.01% | 861 |
|
|
2017
Q1 | $2.13M | Sell |
59,008
-55,389
| -48% | -$2M | 0.01% | 831 |
|
|
2016
Q4 | $5.73M | Buy |
114,397
+1,335
| +1% | +$66.9K | 0.02% | 714 |
|
|
2016
Q3 | $5.93M | Sell |
113,062
-83,288
| -42% | -$4.37M | 0.02% | 698 |
|
|
2016
Q2 | $8.12M | Buy |
196,350
+34,995
| +22% | +$1.45M | 0.03% | 620 |
|
|
2016
Q1 | $6.56M | Buy |
161,355
+8,929
| +6% | +$363K | 0.02% | 644 |
|
|
2015
Q4 | $6.33M | Buy |
152,426
+1,653
| +1% | +$68.6K | 0.02% | 686 |
|
|
2015
Q3 | $2.32M | Sell |
150,773
-125,093
| -45% | -$1.92M | 0.01% | 832 |
|
|
2015
Q2 | $6.85M | Buy |
+275,866
| New | +$6.85M | 0.02% | 710 |
|